Aviva PLC announced on Monday that it had sold its Italian life insurance joint venture Aviva Vita SpA to UBI Banca banking group for € 400 million ($ 474. 2 million).
The FTSE 100 insurer said the deal was another step in its strategy to realign its portfolio.
« Proceeds will be used to further strengthen Aviva’s core liquidity and are considered part of Aviva’s broader capital management and deleveraging goals, » the company said.
Aviva has three other insurance companies operating in Italy, including Aviva SpA – a joint venture with the Italian bank UniCredit SpA – and 100% Aviva Life SpA and Aviva Italia SpA.
AstraZeneca undefinedundefined said its COVID-19 vaccine candidate had met its primary endpoint and demonstrated protection from COVID-19 that occurred 14 days or more after receiving two doses of the vaccine. One dosing regimen showed vaccine effectiveness of 90% when AZD1222 was administered as a half dose followed by a full dose at least one month apart, and another dosing regimen showed 62% effectiveness when two full doses at least one month apart were administered. No serious safety events related to the vaccine have been confirmed. AstraZeneca will now immediately prepare for regulatory submission of the data to authorities around the world that have a framework for conditional or early approval.
By using this website you agree to this
Historical and current end-of-day data from FACTSET.
All offers are in local exchange time.
Last real-time sales data for U. . S.. . Stock market prices only reflect trades reported through Nasdaq.
Intraday data was delayed by at least 15 minutes or as per exchange requirements.
Aviva, UBI Banca, life insurance, Amanda Blanc, share
EbeneMagazine – GB – Aviva sells Italian subsidiary for 400 million. EUR